Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 62 | 2026 | 2586 | 7.350 |
Why?
|
| Homosexuality, Male | 29 | 2026 | 486 | 5.430 |
Why?
|
| Prisoners | 16 | 2025 | 102 | 5.160 |
Why?
|
| Sexually Transmitted Diseases | 12 | 2025 | 174 | 3.400 |
Why?
|
| Anti-HIV Agents | 11 | 2026 | 486 | 3.390 |
Why?
|
| Sexual Behavior | 22 | 2025 | 638 | 2.890 |
Why?
|
| Substance-Related Disorders | 10 | 2025 | 830 | 2.860 |
Why?
|
| Bisexuality | 9 | 2018 | 211 | 1.890 |
Why?
|
| Los Angeles | 26 | 2026 | 394 | 1.840 |
Why?
|
| Continuity of Patient Care | 6 | 2022 | 120 | 1.810 |
Why?
|
| Sexual Partners | 13 | 2022 | 326 | 1.710 |
Why?
|
| Prisons | 11 | 2020 | 54 | 1.460 |
Why?
|
| Male | 68 | 2026 | 23409 | 1.380 |
Why?
|
| Risk-Taking | 12 | 2022 | 457 | 1.290 |
Why?
|
| Humans | 87 | 2026 | 43102 | 1.260 |
Why?
|
| Condoms | 9 | 2018 | 150 | 1.180 |
Why?
|
| Adult | 49 | 2026 | 13872 | 1.160 |
Why?
|
| Unsafe Sex | 7 | 2020 | 162 | 1.110 |
Why?
|
| Peer Group | 4 | 2025 | 177 | 0.980 |
Why?
|
| Female | 45 | 2025 | 24698 | 0.860 |
Why?
|
| United States | 23 | 2024 | 5205 | 0.830 |
Why?
|
| Siblings | 1 | 2023 | 22 | 0.810 |
Why?
|
| Middle Aged | 33 | 2025 | 12222 | 0.810 |
Why?
|
| Central Nervous System Stimulants | 2 | 2022 | 180 | 0.790 |
Why?
|
| Safe Sex | 5 | 2018 | 78 | 0.780 |
Why?
|
| Criminals | 3 | 2020 | 18 | 0.770 |
Why?
|
| Income Tax | 1 | 2022 | 2 | 0.760 |
Why?
|
| Psychiatry | 1 | 2022 | 36 | 0.740 |
Why?
|
| Young Adult | 16 | 2026 | 5080 | 0.680 |
Why?
|
| HIV Seropositivity | 4 | 2014 | 196 | 0.680 |
Why?
|
| Cannabis | 1 | 2023 | 90 | 0.680 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2020 | 12 | 0.650 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2020 | 989 | 0.650 |
Why?
|
| Transsexualism | 2 | 2010 | 20 | 0.630 |
Why?
|
| Risk Reduction Behavior | 3 | 2022 | 138 | 0.620 |
Why?
|
| Patient Participation | 1 | 2020 | 94 | 0.610 |
Why?
|
| Trust | 1 | 2020 | 167 | 0.580 |
Why?
|
| Patient Selection | 1 | 2020 | 205 | 0.580 |
Why?
|
| Heterosexuality | 2 | 2011 | 97 | 0.570 |
Why?
|
| Minority Groups | 2 | 2020 | 690 | 0.510 |
Why?
|
| Behavior Therapy | 2 | 2018 | 180 | 0.480 |
Why?
|
| Health Services Accessibility | 2 | 2024 | 706 | 0.470 |
Why?
|
| Crime | 2 | 2020 | 29 | 0.460 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2019 | 497 | 0.440 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 310 | 0.430 |
Why?
|
| HIV Seroprevalence | 3 | 2004 | 11 | 0.430 |
Why?
|
| Social Identification | 2 | 2016 | 65 | 0.430 |
Why?
|
| HIV | 4 | 2022 | 100 | 0.390 |
Why?
|
| Incidence | 4 | 2026 | 1078 | 0.380 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 193 | 0.380 |
Why?
|
| Interviews as Topic | 3 | 2024 | 452 | 0.380 |
Why?
|
| Adolescent | 15 | 2022 | 6081 | 0.380 |
Why?
|
| Adaptation, Psychological | 1 | 2015 | 420 | 0.370 |
Why?
|
| California | 6 | 2024 | 548 | 0.370 |
Why?
|
| Social Support | 5 | 2025 | 445 | 0.350 |
Why?
|
| Medicaid | 2 | 2024 | 143 | 0.350 |
Why?
|
| Prejudice | 2 | 2009 | 116 | 0.350 |
Why?
|
| Medication Adherence | 2 | 2026 | 182 | 0.340 |
Why?
|
| Income | 3 | 2022 | 160 | 0.340 |
Why?
|
| Qualitative Research | 3 | 2024 | 574 | 0.330 |
Why?
|
| Gender Identity | 3 | 2021 | 117 | 0.320 |
Why?
|
| Health Promotion | 3 | 2022 | 704 | 0.320 |
Why?
|
| Anti-Retroviral Agents | 2 | 2022 | 160 | 0.320 |
Why?
|
| Terminology as Topic | 1 | 2010 | 42 | 0.320 |
Why?
|
| Prevalence | 10 | 2017 | 1612 | 0.310 |
Why?
|
| Preventive Health Services | 1 | 2009 | 66 | 0.290 |
Why?
|
| Health Status Disparities | 3 | 2012 | 719 | 0.290 |
Why?
|
| Aged | 11 | 2023 | 8214 | 0.280 |
Why?
|
| Truth Disclosure | 2 | 2012 | 26 | 0.270 |
Why?
|
| Health Surveys | 2 | 2011 | 405 | 0.260 |
Why?
|
| Self Concept | 1 | 2008 | 171 | 0.260 |
Why?
|
| Logistic Models | 5 | 2020 | 1009 | 0.260 |
Why?
|
| Research | 1 | 2008 | 181 | 0.240 |
Why?
|
| Injections | 1 | 2026 | 42 | 0.240 |
Why?
|
| Age Factors | 5 | 2018 | 1154 | 0.240 |
Why?
|
| Risk Factors | 11 | 2018 | 3994 | 0.240 |
Why?
|
| Delayed-Action Preparations | 1 | 2026 | 74 | 0.230 |
Why?
|
| Attitude | 1 | 2006 | 108 | 0.230 |
Why?
|
| Naloxone | 1 | 2024 | 56 | 0.220 |
Why?
|
| Allostasis | 2 | 2017 | 25 | 0.220 |
Why?
|
| Narcotic Antagonists | 1 | 2024 | 78 | 0.220 |
Why?
|
| Mass Screening | 4 | 2020 | 541 | 0.210 |
Why?
|
| Criminal Law | 2 | 2021 | 28 | 0.210 |
Why?
|
| Academic Medical Centers | 1 | 2024 | 76 | 0.210 |
Why?
|
| Ambulatory Care Facilities | 1 | 2004 | 68 | 0.210 |
Why?
|
| Ambulatory Care | 1 | 2024 | 81 | 0.210 |
Why?
|
| Computer Simulation | 1 | 2026 | 408 | 0.200 |
Why?
|
| Healthcare Disparities | 1 | 2009 | 590 | 0.200 |
Why?
|
| Health Expenditures | 1 | 2023 | 44 | 0.200 |
Why?
|
| Beauty Culture | 1 | 2022 | 2 | 0.190 |
Why?
|
| Methamphetamine | 2 | 2022 | 166 | 0.190 |
Why?
|
| Feasibility Studies | 1 | 2023 | 259 | 0.190 |
Why?
|
| Emigration and Immigration | 1 | 2002 | 85 | 0.190 |
Why?
|
| Focus Groups | 3 | 2018 | 423 | 0.190 |
Why?
|
| Illinois | 4 | 2024 | 12 | 0.190 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 76 | 0.170 |
Why?
|
| Opioid-Related Disorders | 1 | 2024 | 195 | 0.170 |
Why?
|
| Blood Pressure Determination | 1 | 2001 | 54 | 0.170 |
Why?
|
| Hypercholesterolemia | 1 | 2001 | 42 | 0.170 |
Why?
|
| RNA, Viral | 4 | 2018 | 321 | 0.160 |
Why?
|
| Medicare | 1 | 2023 | 332 | 0.160 |
Why?
|
| Sexuality | 2 | 2018 | 56 | 0.160 |
Why?
|
| Mental Health | 2 | 2022 | 385 | 0.160 |
Why?
|
| Disease Transmission, Infectious | 1 | 2019 | 30 | 0.150 |
Why?
|
| Cholesterol | 1 | 2001 | 232 | 0.150 |
Why?
|
| Guideline Adherence | 2 | 2017 | 98 | 0.150 |
Why?
|
| HIV-1 | 4 | 2014 | 755 | 0.140 |
Why?
|
| Coitus | 2 | 2016 | 12 | 0.140 |
Why?
|
| Case Management | 1 | 2018 | 24 | 0.140 |
Why?
|
| Patient Compliance | 1 | 2019 | 233 | 0.140 |
Why?
|
| Mortality | 2 | 2017 | 175 | 0.140 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1081 | 0.130 |
Why?
|
| Personal Autonomy | 1 | 2017 | 22 | 0.130 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 55 | 0.130 |
Why?
|
| Residence Characteristics | 1 | 2020 | 363 | 0.130 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 154 | 0.130 |
Why?
|
| Chicago | 4 | 2020 | 31 | 0.130 |
Why?
|
| Disease Management | 1 | 2017 | 70 | 0.130 |
Why?
|
| Health Behavior | 3 | 2012 | 575 | 0.130 |
Why?
|
| Sex Factors | 2 | 2011 | 1028 | 0.130 |
Why?
|
| Religion | 1 | 2017 | 90 | 0.120 |
Why?
|
| Socioeconomic Factors | 4 | 2020 | 1234 | 0.120 |
Why?
|
| Unemployment | 1 | 2016 | 29 | 0.120 |
Why?
|
| Community Health Services | 1 | 2017 | 206 | 0.120 |
Why?
|
| Cross-Sectional Studies | 7 | 2018 | 3156 | 0.120 |
Why?
|
| Professional-Patient Relations | 1 | 2015 | 60 | 0.110 |
Why?
|
| Self Efficacy | 1 | 2016 | 215 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 1067 | 0.110 |
Why?
|
| Hypertension | 1 | 2001 | 835 | 0.100 |
Why?
|
| Counseling | 2 | 2018 | 138 | 0.100 |
Why?
|
| Interpersonal Relations | 1 | 2015 | 222 | 0.100 |
Why?
|
| Time Factors | 4 | 2017 | 1857 | 0.100 |
Why?
|
| Attitude to Health | 1 | 2015 | 338 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2012 | 2853 | 0.100 |
Why?
|
| Program Evaluation | 1 | 2013 | 359 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 749 | 0.080 |
Why?
|
| Community-Acquired Infections | 1 | 2010 | 22 | 0.080 |
Why?
|
| Hierarchy, Social | 1 | 2010 | 9 | 0.080 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 67 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 2010 | 67 | 0.080 |
Why?
|
| Disease Outbreaks | 1 | 2010 | 175 | 0.080 |
Why?
|
| Sexually Transmitted Diseases, Bacterial | 1 | 2009 | 7 | 0.070 |
Why?
|
| Stress, Psychological | 2 | 2012 | 661 | 0.070 |
Why?
|
| History, 17th Century | 1 | 2009 | 5 | 0.070 |
Why?
|
| History, 18th Century | 1 | 2009 | 6 | 0.070 |
Why?
|
| Viral Load | 3 | 2022 | 348 | 0.070 |
Why?
|
| History, 19th Century | 1 | 2009 | 25 | 0.070 |
Why?
|
| Culture | 1 | 2010 | 172 | 0.070 |
Why?
|
| Contact Tracing | 1 | 2009 | 25 | 0.070 |
Why?
|
| Internal-External Control | 1 | 2009 | 63 | 0.070 |
Why?
|
| Demography | 1 | 2009 | 195 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2009 | 121 | 0.070 |
Why?
|
| Urban Population | 2 | 2016 | 374 | 0.070 |
Why?
|
| Community Networks | 1 | 2009 | 107 | 0.070 |
Why?
|
| Philadelphia | 2 | 2018 | 20 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2012 | 392 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2009 | 142 | 0.070 |
Why?
|
| Cultural Competency | 1 | 2009 | 138 | 0.070 |
Why?
|
| HIV Antibodies | 2 | 2004 | 24 | 0.060 |
Why?
|
| Decision Making | 1 | 2009 | 249 | 0.060 |
Why?
|
| Age Distribution | 2 | 2003 | 249 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2020 | 1759 | 0.060 |
Why?
|
| Anonymous Testing | 1 | 2004 | 1 | 0.060 |
Why?
|
| Washington | 1 | 2004 | 38 | 0.050 |
Why?
|
| Southwestern United States | 1 | 2004 | 47 | 0.050 |
Why?
|
| Motivation | 1 | 2008 | 513 | 0.050 |
Why?
|
| Costs and Cost Analysis | 1 | 2023 | 60 | 0.050 |
Why?
|
| Marital Status | 1 | 2003 | 46 | 0.050 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2004 | 129 | 0.050 |
Why?
|
| Depression | 2 | 2023 | 863 | 0.040 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 1999 | 74 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2003 | 587 | 0.040 |
Why?
|
| Managed Care Programs | 1 | 2001 | 40 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 1999 | 184 | 0.040 |
Why?
|
| Texas | 1 | 2022 | 457 | 0.040 |
Why?
|
| Forecasting | 1 | 2020 | 136 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 1997 | 249 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 440 | 0.040 |
Why?
|
| Water Pollution | 1 | 1999 | 13 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1999 | 11 | 0.040 |
Why?
|
| Swimming | 1 | 1999 | 41 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 1997 | 117 | 0.040 |
Why?
|
| Water Microbiology | 1 | 1999 | 81 | 0.040 |
Why?
|
| Linear Models | 1 | 2019 | 317 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2019 | 195 | 0.040 |
Why?
|
| Pregnancy | 3 | 1999 | 1772 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2018 | 1600 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 611 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 252 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2014 | 883 | 0.030 |
Why?
|
| Antibodies, Viral | 2 | 2014 | 306 | 0.030 |
Why?
|
| Cocaine | 1 | 2019 | 251 | 0.030 |
Why?
|
| Cause of Death | 1 | 2017 | 186 | 0.030 |
Why?
|
| Child | 1 | 2004 | 3443 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 518 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2001 | 609 | 0.030 |
Why?
|
| Aging | 1 | 2001 | 783 | 0.030 |
Why?
|
| Housing | 1 | 2016 | 74 | 0.030 |
Why?
|
| Intention | 1 | 2016 | 108 | 0.030 |
Why?
|
| Alcoholism | 2 | 2013 | 305 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 737 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 1604 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 861 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2014 | 10 | 0.030 |
Why?
|
| Algorithms | 1 | 2017 | 509 | 0.030 |
Why?
|
| Immunoassay | 1 | 2014 | 74 | 0.030 |
Why?
|
| Urban Health | 1 | 2013 | 101 | 0.030 |
Why?
|
| Emotions | 1 | 2016 | 254 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 179 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2010 | 1285 | 0.020 |
Why?
|
| Behavior | 1 | 2010 | 35 | 0.020 |
Why?
|
| Carrier State | 1 | 2010 | 33 | 0.020 |
Why?
|
| San Francisco | 1 | 2010 | 35 | 0.020 |
Why?
|
| HIV Core Protein p24 | 2 | 2001 | 12 | 0.020 |
Why?
|
| Social Class | 1 | 2012 | 291 | 0.020 |
Why?
|
| beta 2-Microglobulin | 2 | 1999 | 10 | 0.020 |
Why?
|
| Neopterin | 2 | 1999 | 13 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 760 | 0.020 |
Why?
|
| Health Policy | 1 | 2009 | 184 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 2 | 1997 | 91 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 1999 | 279 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 1999 | 384 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2003 | 224 | 0.010 |
Why?
|
| Educational Status | 1 | 2003 | 339 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2001 | 28 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2001 | 114 | 0.010 |
Why?
|
| Oceans and Seas | 1 | 1999 | 18 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 1999 | 29 | 0.010 |
Why?
|
| Sewage | 1 | 1999 | 27 | 0.010 |
Why?
|
| Enterobacteriaceae | 1 | 1999 | 30 | 0.010 |
Why?
|
| Leisure Activities | 1 | 1999 | 41 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1997 | 57 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1997 | 127 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1997 | 201 | 0.010 |
Why?
|
| Postpartum Period | 1 | 1997 | 92 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1997 | 972 | 0.010 |
Why?
|
| Phenotype | 1 | 1997 | 780 | 0.010 |
Why?
|
| Infant | 1 | 1997 | 1175 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 1997 | 2544 | 0.010 |
Why?
|